406 related articles for article (PubMed ID: 31663464)
21. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
Wang J; Brown LM; Hong SH
J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
[TBL] [Abstract][Full Text] [Related]
22. Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas.
Nathan AS; Yang L; Yang N; Eberly LA; Khatana SAM; Dayoub EJ; Vemulapalli S; Julien H; Cohen DJ; Nallamothu BK; Baron SJ; Desai ND; Szeto WY; Herrmann HC; Groeneveld PW; Giri J; Fanaroff AC
JAMA Cardiol; 2022 Feb; 7(2):150-157. PubMed ID: 34787635
[TBL] [Abstract][Full Text] [Related]
23. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.
Lu D; Qiao Y; Johnson KC; Wang J
J Asthma; 2017 Jun; 54(5):504-513. PubMed ID: 27676212
[TBL] [Abstract][Full Text] [Related]
24. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.
Kalidindi Y; Jung J; Feldman R; Riley T
JAMA Netw Open; 2020 Jul; 3(7):e2011055. PubMed ID: 32692371
[TBL] [Abstract][Full Text] [Related]
25. Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.
Socías ME; Ti L; Wood E; Nosova E; Hull M; Hayashi K; Debeck K; Milloy MJ
Liver Int; 2019 Aug; 39(8):1400-1407. PubMed ID: 30653809
[TBL] [Abstract][Full Text] [Related]
26. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.
Biggers A; Shi Y; Charlson J; Smith EC; Smallwood AJ; Nattinger AB; Laud PW; Neuner JM
J Clin Oncol; 2016 Dec; 34(36):4398-4404. PubMed ID: 27998232
[TBL] [Abstract][Full Text] [Related]
27. High sustained virologic response rates, regardless of race or socioeconomic class, in patients treated with chronic hepatitis C in community practice using a specialized pharmacy team.
Kuwelker S; Tsai E; Kuo L; Kim J; Van Frank T; Mitchell R; Ramirez R; Guerrero R; Hanysak B; Landaverde C; Rodas F; Lawitz E; Basra T; Nguyen H; Christensen K; Vaughn C; Hinojosa K; Olvera N; Caraballo-Gonzalez E; Pham E; Pedicone LD; Poordad F
Medicine (Baltimore); 2023 Jul; 102(30):e34183. PubMed ID: 37505173
[TBL] [Abstract][Full Text] [Related]
28. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
29. Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation.
Eberly LA; Garg L; Yang L; Markman TM; Nathan AS; Eneanya ND; Dixit S; Marchlinski FE; Groeneveld PW; Frankel DS
JAMA Netw Open; 2021 Feb; 4(2):e210247. PubMed ID: 33635328
[TBL] [Abstract][Full Text] [Related]
30. Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries.
Tran L; Jung J; Feldman R; Riley T
PLoS One; 2022; 17(3):e0263913. PubMed ID: 35271617
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C Treatment Initiation Among US Medicaid Enrollees.
Kapadia SN; Zhang H; Gonzalez CJ; Sen B; Franco R; Hutchings K; Wethington E; Talal A; Lloyd A; Dharia A; Wells M; Bao Y; Shapiro MF
JAMA Netw Open; 2023 Aug; 6(8):e2327326. PubMed ID: 37540513
[TBL] [Abstract][Full Text] [Related]
32. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
[TBL] [Abstract][Full Text] [Related]
33. A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service Program.
Hall LL; Xu L; Mahmud SM; Puckrein GA; Thommes EW; Chit A
Adv Ther; 2020 May; 37(5):2224-2235. PubMed ID: 32274750
[TBL] [Abstract][Full Text] [Related]
34. Geographic Variation and Disparities in Total Joint Replacement Use for Medicare Beneficiaries: 2009 to 2017.
Thirukumaran CP; Cai X; Glance LG; Kim Y; Ricciardi BF; Fiscella KA; Li Y
J Bone Joint Surg Am; 2020 Dec; 102(24):2120-2128. PubMed ID: 33079898
[TBL] [Abstract][Full Text] [Related]
35. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
36. Racial/ethnic disparities in Medicare Part D experiences.
Haviland AM; Elliott MN; Weech-Maldonado R; Hambarsoomian K; Orr N; Hays RD
Med Care; 2012 Nov; 50 Suppl(Suppl):S40-7. PubMed ID: 23064276
[TBL] [Abstract][Full Text] [Related]
37. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
[TBL] [Abstract][Full Text] [Related]
38. Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection.
van Boemmel-Wegmann S; Lo Re V; Park H
Dig Dis Sci; 2020 Nov; 65(11):3159-3174. PubMed ID: 31938995
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
[TBL] [Abstract][Full Text] [Related]
40. Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis.
Herink MC; Geddes J; Vo K; Zaman A; Hartung DM
J Manag Care Spec Pharm; 2021 Jul; 27(7):856-864. PubMed ID: 34185560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]